title: Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.
abstract: Gastroparesis is a very common non-motor feature in Parkinson's disease (PD) patients. However, treatment options are limited and difficult. We present 2 cases of PD patients with excellent response to botulinum toxin type A as treatment for PD-related gastroparesis.
authors.affiliation: Parkinson's Disease Treatment Center of SW Florida (d/b/a Charlotte Neurological Services), 4235 Kings Highway, Port Charlotte, FL 33980, USA. gilramon@hotmail.com
authors.forename: Ramon A
authors.initials: RA
authors.lastname: Gil
authors.forename: Nelson
authors.initials: N
authors.lastname: Hwynn
authors.forename: Thomas
authors.initials: T
authors.lastname: Fabian
authors.forename: Sovi
authors.initials: S
authors.lastname: Joseph
authors.forename: Hubert H
authors.initials: HH
authors.lastname: Fernandez
mesh_terms: D000368:Aged; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005260:Female; D005746:Gastric Emptying / Q000187:drug effects; D018589:Gastroparesis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000150:complications*
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A